| May. 07, 2008 | Print This | Email This |
| |
|
|
|
OTC drug sales account for between 8% and 30% of total pharmaceutical sales in the majority of world regions. In developed regions, such as the U.S. and the U.K., they accounted for 7.7% and 15.8% respectively in 2007. Higher percentages of OTC sales are often found in regions that are less developed, such as India or China.
"The state of the economy, lifestyle, culture, the time it takes to see a doctor and the condition of medical care all contribute to people seeking to self-medicate," notes Kalorama analyst Melissa Elder. "While it's not the optimal method of treatment, and could lead to complications and undiagnosed conditions, it is nonetheless an important factor driving sales, especially in emerging countries like China."
Kalorama Information's report World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends covers the latest OTC trends, and developments in North and South America, Asia Pacific/Africa and Europe. The report includes market size, forecasts, health statistics, demographic data, product information and company profiles. It can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/OTC-Pharmaceutical-1614108/.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. Kalorama routinely assists media with healthcare topics, and can provide experts to speak about markets in the life sciences industry. For more information, contact Andrea Hiller at 212-807-2673 or press@kaloramainformation.com, or visit http://www.kaloramaInformation.com.
Kalorama InformationCONTACT: Andrea Hiller for Kalorama Information, +1-212-807-2673,
press@kaloramainformation.com
Web site: http://www.kaloramaInformation.com/

